Get started
Author

Takuya Haraguchi

Observed name: TAKUYA HARAGUCHI
ORCID: 0009-0004-5218-8479
Observed ORCID: 0009-0004-5218-8479
OpenAlex ID: A5111304636
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial
2019 · Kausik K Ray, Helen M Colhoun, et al. · The Lancet Diabetes & Endocrinology · 315
PDF
Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol
2021 · Gregory G. Schwartz, Gregory G. Schwartz, et al. · Journal of the American College of Cardiology · 148
PDF
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab
2022 · Emil Hagström, P. Gabriel Steg, et al. · Circulation · 118
PDF
Sodium‐glucose co‐transporter‐2 inhibitor use and dietary carbohydrate intake in J apanese individuals with type 2 diabetes: A randomized, open‐label, 3‐arm parallel comparative, exploratory study
2016 · Daisuke Yabe, Masahiro Iwasaki, et al. · Diabetes Obesity and Metabolism · 67
PDF
Effects of glucagon‐like peptide‐1 receptor agonists on secretions of insulin and glucagon and gastric emptying in Japanese individuals with type 2 diabetes: A prospective, observational study
2021 · Hitoshi Kuwata, Daisuke Yabe, et al. · Journal of Diabetes Investigation · 42
PDF
Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment
2021 · Gregory G. Schwartz, Michael Szarek, et al. · Diabetes Care · 40
PDF
Lifestyle changes as a result of COVID‐19 containment measures: Bodyweight and glycemic control in patients with diabetes in the Japanese declaration of a state of emergency
2021 · Nagaaki Tanaka, Yoshiyuki Hamamoto, et al. · Journal of Diabetes Investigation · 36
PDF
Relation of Low-Density Lipoprotein Cholesterol, High-Sensitivity C-Reactive Protein, and Lipoprotein(a) Each to Future Cardiovascular Events and Death After Acute Coronary Syndrome on High-Intensity Statin Therapy: An Analysis of the Placebo Arm of ODYSSEY OUTCOMES
2025 · P. Gabriel Steg, Michael Szarek, et al. · Circulation · 26
PDF
Effect of Roxadustat on Thyroid Function in Patients With Renal Anemia
2023 · Takuya Haraguchi, Yoshiyuki Hamamoto, et al. · The Journal of Clinical Endocrinology & Metabolism · 26
Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation
2024 · Shaun G Goodman, Philippe Gabriel Steg, et al. · European Heart Journal - Cardiovascular Pharmacotherapy · 25
PDF
Stigma evaluation for diabetes and other chronic non‐communicable disease patients: Development, validation and clinical use of stigma scale – The Kanden Institute Stigma Scale
2022 · Nagaaki Tanaka, Yoshiyuki Hamamoto, et al. · Journal of Diabetes Investigation · 13
Association of dipeptidyl peptidase‐4 inhibitor use and risk of pancreatic cancer in individuals with diabetes in Japan
2022 · Sodai Kubota, Takuya Haraguchi, et al. · Journal of Diabetes Investigation · 10
PDF
Intestinal fructose metabolism triggers a glucagon‐like peptide‐1–β‐cell axis to prevent post‐fructose hyperglycaemia
2025 · Naoya Murao, Yusuke Seino, et al. · The Journal of Physiology · 9
Glucagon Stimulation Test and Insulin Secretory Capacity in the Clinical Assessment of Incretin-Based Therapy for Diabetes
2024 · Takuya Haraguchi, Yuji Yamazaki, et al. · Diabetes · 6
Sequence of Eating at Japanese-Style Set Meals Improves Postprandial Glycemic Elevation in Healthy People
2025 · Yuri Kurotobi, Hitoshi Kuwata, et al. · Nutrients · 2
Effects of Steroid Therapy on Pancreatic Endocrine Function in IgG4-related AIP: Evaluation by Arginine Stimulation Test
2025 · Mari Matsushiro, Takuya Haraguchi, et al. · JCEM Case Reports · 1
Acute high‐protein feeding induces hepatic amino acid accumulation in diabetic male mice prior to transcriptional adaptation
2026 · Hiroaki Sumioki, Eisuke Tomatsu, et al. · Physiological Reports
Intestinal fructose metabolism triggers a GLP-1–β-cell axis to prevent post-fructose hyperglycaemia
2025 · Naoya Murao, Yusuke Seino, et al. · bioRxiv (Cold Spring Harbor Laboratory)
PDF
Glucagon Stimulation Test and Insulin Secretory Capacity in Clinical Assessment of Incretin-Based Therapy for Diabetes
2024 · Takuya Haraguchi, Yuji Yamazaki, et al.
Glucagon Stimulation Test and Insulin Secretory Capacity in Clinical Assessment of Incretin-Based Therapy for Diabetes
2024 · Takuya Haraguchi, Yuji Yamazaki, et al.
687-P: ß-Cell Function and Glycemic Response to Dulaglutide in Patients with Type 2 Diabetes
2021 · MASASHI HASEBE, SATOSHI YOSHIJI, et al. · Diabetes
Works count: 21
Citation count: 882
H-index: 11
I10-index: 12
Year
Topic
Type